Related Experiment Video
Updated: May 7, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hyperglycemia and mortality among patients with coronary artery disease
Insights
Coronary artery disease (CAD) patients with impaired glucose regulation (IGR) or diabetes face a higher risk of death. Early identification and management of glucose abnormalities are crucial for improving outcomes in CAD patients.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Known diabetes is a significant risk factor for mortality in patients with coronary artery disease (CAD).
- The association between other glucose abnormalities and mortality risk in CAD patients remains unclear.
- Understanding these associations is vital for comprehensive patient management and risk stratification.
Purpose of the Study:
- To investigate the relationship between various glucose states and the risk of all-cause and cardiovascular disease (CVD) mortality in CAD patients.
- To determine if glucose abnormalities beyond known diabetes increase mortality risk.
Main Methods:
- A cohort of 1,726 CAD patients aged 40-85 years was analyzed.
- Cox proportional hazards regression models were employed to assess the association between baseline glucose status and mortality risk.
- Multivariable adjustments were made for numerous clinical and demographic factors.
Main Results:
- Over a median follow-up of 3.1 years, 129 deaths occurred, with 109 from CVD.
- Impaired glucose regulation (IGR), newly diagnosed diabetes, and known diabetes were associated with significantly increased all-cause and CVD mortality.
- Specifically, hazard ratios for CVD mortality were 1.89 for IGR, 2.74 for newly diagnosed diabetes, and 2.73 for known diabetes compared to normoglycemia.
Conclusions:
- CAD patients with IGR, newly diagnosed diabetes, or known diabetes exhibit an elevated risk of cardiovascular disease mortality.
- These findings underscore the importance of monitoring and managing glucose levels in all CAD patients, not just those with diagnosed diabetes.
Objective:
Known diabetes is an independent predictor for mortality in coronary artery disease (CAD) patients; however, whether other glucose abnormalities are associated with death risk in CAD patients is unclear. The goal of this study was to examine the association between different glucose states and the risks of all-cause and cardiovascular disease (CVD) mortality among CAD patients.
Research Design And Methods:
The study cohort included 1,726 CAD patients who were 40-85 years of age in the Guangdong Coronary Artery Disease Cohort. Cox proportional hazards regression models were used to estimate the association of baseline glucose status with risk of mortality.
Results:
During a median follow-up of 3.1 years, 129 deaths were recorded, 109 of which were due to CVD. The multivariable-adjusted (age; sex; education; marriage; leisure-time physical activity; smoking; alcohol drinking; BMI; systolic blood pressure; total and HDL cholesterol; glomerular filtration rate; type, severity, duration, and treatment of CAD; history of heart failure; and use of antihypertensive, cholesterol-lowering, and antiplatelet drugs) hazard ratios in normoglycemia, impaired glucose regulation (IGR), newly diagnosed diabetes, and known diabetes were 1.00, 1.58 (95% CI 0.90-2.77), 2.41 (1.42-4.11), and 2.29 (1.36-3.84) for all-cause mortality and 1.00, 1.89 (1.01-3.54), 2.74 (1.50-5.01), and 2.73 (1.52-4.91) for CVD mortality. Assessing fasting plasma glucose only, impaired fasting glucose and newly diagnosed and known diabetes were also associated with increased risks of all-cause and CVD mortality compared with normoglycemia.
Conclusions:
CAD patients with IGR, newly diagnosed diabetes, and known diabetes have increased risk of CVD mortality.
Related Concept Videos
Hyperglycemia
Hypoglycemia and Glucagon
Hypoglycemia
Complications of Diabetes Mellitus
Diabetes: Symptoms, Diagnosis, and Complications
Type I Diabetes III: Clinical Manifestations

